Retatrutide 12mg

Retatrutide is an experimental drug being developed for obesity and related metabolic conditions.
Retatrutide is unique because it activates three hormone receptors:

1. GLP-1 (glucagon-like peptide-1) receptor
* Reduces appetite
* Slows stomach emptying
* Improves blood sugar control
2. GIP (glucose-dependent insulinotropic polypeptide) receptor
* Enhances insulin response
* May improve metabolic effects when combined with GLP-1 activity
3. Glucagon receptor
* Increases energy expenditure (calorie burning)
* May contribute to greater weight loss than GLP-1 drugs alone

Potential benefits

Research suggests retatrutide may:

* Produce substantial weight loss
* Improve blood sugar control in people with diabetes
* Reduce liver fat in people with fatty liver disease
* Improve cardiovascular and metabolic risk factors